Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Acadia Pharmaceutica (NQ: ACAD)
51.61 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 6:36 PM EDT, Jul 2, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 51.61
Bid (Size) 42.32 (1)
Ask (Size) 52.77 (2)
Prev. Close 51.61
Today's Range 51.61 - 51.61
52wk Range 21.56 - 53.75
Shares Outstanding 124,825,969
Dividend Yield N/A
Performance
YTD
+25.54%
+25.54%
1 Month
+13.16%
+13.16%
3 Month
+19.22%
+19.22%
6 Month
+20.56%
+20.56%
1 Year
+92.79%
+92.79%
Top News
More News
Top Biotech Stocks To Watch Today; 1 Up More Than 100% This Week
from Stockmarket.com
ACADIA Pharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for NUPLAZID® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that the company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to support a potential... Read More
from Business Wire News Releases
More News
Read More
ACADIA Pharmaceuticals to Present at the Goldman Sachs 41st Annual Global Healthcare Conference on June 9, 2020
from Business Wire News Releases
August 14th Options Now Available For Acadia Pharmaceuticals (ACAD)
category Stocks
from Market News Video
Analysts Forecast 13% Gains Ahead For FBT
category ETFs
from ETF Channel
ACADIA Pharmaceuticals Appoints Mark Schneyer as Senior Vice President, Business Development and Chief Business Officer
from Business Wire News Releases
ACADIA Pharmaceuticals to Combine CLARITY-2 and CLARITY-3 Phase 3 Studies Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder
from Business Wire News Releases
ACADIA Pharmaceuticals to Present Pimavanserin Clinical Data at the 2020 American Society of Clinical Psychopharmacology Virtual Annual Meeting
from Business Wire News Releases
This Way Or That…
category Stocks / Equities
from Blogs - TalkMarkets
Interesting ACAD Put And Call Options For July 24th
category Stocks
from Market News Video
2 Biotech Stocks With Major Incoming Catalysts
category Market News , ACAD , YMAB
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.